It’s inspiring to support founders, executives and investors in realizing successful outcomes from the effort, sacrifices and capital investments they put into building high-quality organizations.
Brian provides healthcare companies with strategic advice and perspective regarding their businesses, including company positioning, market trends, financing options, strategic alternatives, valuation and timing. He has more than 20 years of mergers and acquisitions (M&A) and investment banking experience, working in partnership with management teams, boards of directors, venture capital and growth equity firms. Brian’s M&A advisory experience includes successful engagements for both private and public companies, U.S. domestic and cross-border transactions, reverse mergers, divestitures and special situation assignments across all segments of healthcare with a primary focus on life sciences companies.
Brian understands the value drivers for healthcare companies and how to position these companies to prospective buyers or investors. Lincoln’s fully-integrated global footprint allows Brian to provide his clients with greater access to a broad set of strategic buyers and investors, helping them orchestrate a robust and international process to maximize shareholder returns.
Prior to joining Lincoln, Brian was a managing director in JMP Securities’ healthcare investment banking group and a key contributor in establishing the firm’s healthcare practice. Previously, Brian worked in the healthcare investment banking group at RBC Capital Markets, where he focused on life sciences clients.
Brian earned a Bachelor of Science from Northern Arizona University.
Recent Transactions in Healthcare
Lincoln International is pleased to have advised the partners of Scarsdale Vets on the sale to Independent Vetcare, a portfolio company of EQT Partners
Lincoln is pleased to announce that it has advised Aksìa Group SGR on the sale of Lameplast to Tekni-Plex
Lincoln International is pleased to announce that Nelipak Healthcare Packaging, a portfolio company of Mason Wells, has been sold to Kohlberg & Company
Lincoln International is delighted to have represented Handicare Group in its divestment of Puls, a leading distributor of third-party medical consumables and capital goods in Norway and Denmark, to Mediq International
Lincoln International advised on the sale of Nova IVI, India’s second largest provider of fertility treatment services, to TPG Growth
Lincoln International is pleased to have advised Livingbridge on the sale of their minority stake in CREATE Fertility back to the management team
Lincoln International is pleased to announce the successful sale of C³ (Cannabinoid Compound Company), a subsidiary of Bionorica SE, a producer and marketer of cannabis-based therapeutic compounds, to Canopy Growth
Lincoln International is pleased to have advised Tikehau Capital on its £23 million minority investment into Medtrade, a UK based manufacturer of advanced woundcare and consumer healthcare products
Perspectives by Brian Bock
U.S.-China tensions, tariffs and tightening regulations
Tension and tariffs drives Chinese M&A activity to markets outside the U.S. Mounting tension between Washington, D.C. and Beijing are top of mind in the dealmaking climate. As tariffs continue to dominate […]
Q&A: The evolution of medtech in a globalizing industry
View original post from Pitchbook on May 29, 2019 here. […]
Meet our Senior Team
I work hand in hand with clients to help drive business improvements and strategic positioning.